Jeremy Kilburn, MD
Radiation Oncology · Spartanburg, SCNPI 1831325919
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $283 and has fallen 83.6% since, to $46 in 2025.
Across 26 payments — averaging $34.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novocure Inc.$155
- Boston Scientific$145
- Monteris Medical Corporation$116
- Elekta, Inc.$98
- Brainlab, Inc.$74
- Ipsen Biopharmaceuticals, Inc$57
- plus $261 from 12 others
What the payments were for
- Food & beverage$89499%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novocure Inc. | 2 | $155 |
| Boston Scientific | 1 | $145 |
| Monteris Medical Corporation | 1 | $116 |
| Elekta, Inc. | 1 | $98 |
| Brainlab, Inc. | 4 | $74 |
| Ipsen Biopharmaceuticals, Inc | 3 | $57 |
| GT Medical Technologies, Inc | 1 | $56 |
| Pfizer | 2 | $43 |
| AstraZeneca | 2 | $36 |
| Eisai Inc. | 1 | $25 |
| Tersera Therapeutics LLC | 1 | $15 |
| Bristol Myers Squibb | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
| Astellas Pharma US Inc | 1 | $13 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
| Verastem, Inc. | 1 | $12 |
| Bayer | 1 | $12 |
| Clovis Oncology, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SpaceOAR VUE System - 10mL$145
- Oncology$137
- Neuroblate$116
How this compares
$906 in reported general payments places this provider in the 60th percentile of 72 radiation oncology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 15 | $1,997 |
| Lidocaine Hcl ViscousLidocaine Hcl | 63 | $863 |
| Tamsulosin Hcl | 88 | $807 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 32 | $804 |
| Fentanyl | 15 | $794 |
| Bicalutamide | 14 | $384 |
| Dexamethasone | 16 | $345 |
| Oxycodone Hcl | 13 | $255 |
| Zolpidem Tartrate | 11 | $122 |
| Ciprofloxacin Hcl | 17 | $56 |
| Lorazepam | 14 | $54 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Spartanburg
- Daniel FriedSpartanburg$57K
- Terese HowesSpartanburg$2K
- Heather AllenSpartanburg$593
- Drew MonittoSpartanburg$510
- Amarinthia CurtisSpartanburg$250
- Clinton MedberyCharleston$37K
- Brian LallyCharleston$29K
- Kurt MeyerColumbia$12K
- Kevin BlasColumbia$11K
- David MarshallCharleston$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.